Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
ACS Applied Materials & Interfaces
|
August 9, 2023
The Impact of Intergrain Phases on the Ionic Conductivity of the LAGP Solid Electrolyte Material Prepared by Spark Plasma Sintering
Sorina Cretu, David G Bradley, Li Patrick Wen Feng, et al.
ACS Nano
|
June 9, 2025
Multitechnique Detection of Lead Iodide Hybrid Perovskite Degradation Pathways under Varying Electric Fields
Linh Lan Nguyen, Qiannan Zhang, David G Bradley, et al.
Investigational New Drugs
|
July 14, 2005
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
Susan M Chang, Patrick Wen, Timothy Cloughesy, et al.
Blood
|
July 2, 2008
CNS Hodgkin lymphoma
Elizabeth R Gerstner, Lauren E Abrey, David Schiff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2007
Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study
Monica E Loghin, Michael D Prados, Patrick Wen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans
W Nicholas Haining, Jeffrey Davies, Holger Kanzler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2005
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study
Timothy F Cloughesy, John Kuhn, H Ian Robins, et al.
Neuro-Oncology
|
August 8, 2014
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
Thomas J Kaley, Patrick Wen, David Schiff, et al.
Journal of Neuro-Oncology
|
October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02
Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2004
Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study
Vinay K Puduvalli, W K Alfred Yung, Kenneth R Hess, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
ACS Applied Materials & Interfaces
|
August 9, 2023
The Impact of Intergrain Phases on the Ionic Conductivity of the LAGP Solid Electrolyte Material Prepared by Spark Plasma Sintering
Sorina Cretu, David G Bradley, Li Patrick Wen Feng, et al.
ACS Nano
|
June 9, 2025
Multitechnique Detection of Lead Iodide Hybrid Perovskite Degradation Pathways under Varying Electric Fields
Linh Lan Nguyen, Qiannan Zhang, David G Bradley, et al.
Investigational New Drugs
|
July 14, 2005
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
Susan M Chang, Patrick Wen, Timothy Cloughesy, et al.
Blood
|
July 2, 2008
CNS Hodgkin lymphoma
Elizabeth R Gerstner, Lauren E Abrey, David Schiff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2007
Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study
Monica E Loghin, Michael D Prados, Patrick Wen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans
W Nicholas Haining, Jeffrey Davies, Holger Kanzler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2005
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study
Timothy F Cloughesy, John Kuhn, H Ian Robins, et al.
Neuro-Oncology
|
August 8, 2014
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
Thomas J Kaley, Patrick Wen, David Schiff, et al.
Journal of Neuro-Oncology
|
October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02
Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2004
Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study
Vinay K Puduvalli, W K Alfred Yung, Kenneth R Hess, et al.
Page
of 4